I HEAL for Breast Cancer Survivors With Diabetes
I HEAL
Improving Health Engagement and Lifestyle Management for Breast Cancer Survivors With Diabetes
1 other identifier
interventional
80
1 country
1
Brief Summary
The proposed randomized clinical trial evaluates a diabetes coping skills training (DCST) intervention for improving breast cancer survivors' abilities to manage symptoms and adhere to recommended diabetes self-management. The telephone-based DCST protocol integrates three key strategies to reduce symptoms and improve diabetes self-management: coping skills training for managing symptoms, adherence skills training, and healthy lifestyle skills training. The investigator will test the effects of the DCST intervention by comparing it to diabetes education alone. Physical symptoms, psychological distress, diabetes self-management behaviors, and self-efficacy for managing symptoms and diabetes self-management will be assessed at baseline and 3, 6, and 12 months. Physical activity (i.e., daily steps and distance) will be assessed using wireless activity trackers and data will be obtained from home blood glucose monitoring devices. Glycosylated hemoglobin (HbA1c) will be assessed at baseline, 6, and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes
Started Apr 2017
Longer than P75 for not_applicable diabetes
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2016
CompletedFirst Posted
Study publicly available on registry
November 22, 2016
CompletedStudy Start
First participant enrolled
April 20, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 15, 2022
February 1, 2022
4.6 years
October 21, 2016
February 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in physical symptoms
The Checklist measures the severity of different symptoms (e.g., pain, fatigue, numbness and tingling) associated with illness and disease.
baseline, 3 months, 6 months and 12 months
Change in psychological distress
The eight-item Patient Reported Outcomes Information System (PROMIS).
baseline, 3 months, 6 months and 12 months
Change in psychological distress
Anxiety will be assessed using the seven-item GAD-7 Scale.
baseline, 3 months, 6 months and 12 months
Secondary Outcomes (8)
Accessing change in Diabetes self-management behaviors via self reported medication adherence
Baseline to 12 months
Accessing change in Diabetes self-management behavior via Barriers to taking medication
Baseline to 12 months
Accessing change in Diabetes self-management behavior via Adherence to diabetes self-management behaviors
Baseline to 12 months
Accessing change in Diabetes self-management behavior via Use of home blood glucose monitoring
Baseline, 6 months and 12 months
Improved glycemic control
Baseline, 6 months and 12 months
- +3 more secondary outcomes
Study Arms (2)
Diabetes Coping Skills training (DCST)
EXPERIMENTALTwelve sessions are delivered over 6 months using a faded contact model involving 6 weekly sessions, 3 biweekly sessions and 3 monthly sessions.
Diabetes Education
NO INTERVENTIONone 60 minute diabetes education session.
Interventions
Diabetes Coping Skills Training (DCST) consist of twelve 50 minutes sessions delivered over 6 months using a faded contact model ( 6 weekly session, 3 biweekly sessions and 3 monthly sessions)
Eligibility Criteria
You may qualify if:
- diagnosis of Stage I to III breast cancer,
- diagnosis of diabetes mellitus type 2
- completed local definitive treatment (i.e., surgical treatment, chemotherapy and/or radiation therapy),
- physician verification of ability to participate in the intervention,
- English speaking.
You may not qualify if:
- \<21 years of age,
- severe cognitive or hearing impairment,
- unable to provide meaningful consent (i.e., impairment such that descriptions of the research are not clearly understood),
- presence of a health problem that precludes safe participation in the intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
Related Publications (1)
Shelby RA, Dorfman CS, Arthur SS, Bosworth HB, Corsino L, Sutton L, Owen L, Erkanli A, Keefe F, Corbett C, Kimmick G. Improving health engagement and lifestyle management for breast cancer survivors with diabetes. Contemp Clin Trials. 2020 May;92:105998. doi: 10.1016/j.cct.2020.105998. Epub 2020 Apr 11.
PMID: 32289471DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rebecca A Shelby, PhD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2016
First Posted
November 22, 2016
Study Start
April 20, 2017
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
March 15, 2022
Record last verified: 2022-02